We conducted a study to determine the presence or absence of Helicobacter pylori and laryngopharyngeal reflux (LPR) in 43 previously untreated patients who had presented with a laryngeal lesion. Our aim was to determine if there was any association among H pylori, LPR, and laryngeal lesions. H pylori status was determined by real-time polymerase chain reaction (PCR) assays of biopsy tissue obtained during direct laryngoscopy. The presence or absence of LPR was determined on the basis of patients' reflux symptom index (RSI) and reflux finding score (RFS), which were based on their questionnaire responses and findings on endoscopic examination of the larynx, respectively. Patients with an RSI of 14 or more and/or an RFS of 8 or more were considered to have LPR. H pylori was present in 24 patients (55.8%) and absent in 19 (44.2%)-not a statistically significant difference. The prevalence of LPR was higher than the prevalence of H pylori; it was present in 30 patients (69.8%) and absent in 13 (30.2%). The difference was statistically significant (p = 0.01). We found no association between H pylori status and LPR status. Additionally, we analyzed two subgroups based on whether their lesions were benign or malignant/premalignant and found a significant relation-ship between LPR positivity and the presence of malignant/ premalignant laryngeal lesions (p = 0.03). We found no association between H pylori status and either of the two subgroup categories.
Introduction
Helicobacter pylori bacteria were first isolated in the stomachs of gastric ulcer patients by Marshall et al. 1 H pylori is a microaerophilic, gram-negative spiral organism that has been shown to be the causative factor in a large proportion of patients with stomach ulcers and gastritis. 2, 3 It has also been associated with laryngopharyngeal reflux (LPR) and gastric cancer. 4, 5 H pylori has been found in human dental plaque, oral lesions, saliva, tonsils, and sinonasal and adenoid tissues. [6] [7] [8] [9] [10] [11] [12] LPR has been reported to be associated with a host of laryngeal conditions, including inappropriate muscle tension (functional dysphonia), subglottic stenosis, laryngospasm, pachydermia, leukoplakia, and vocal fold carcinoma. The most common symptoms associated with LPR are hoarseness, dysphagia, globus pharyngeus, cough, and excessive throat clearing; these symptoms are nonspecific, as they may also be caused by laryngeal pathologies such as neoplasia and polyps. Common laryngeal findings are localized or diffuse laryngeal edema, ventricular obliteration, erythema, hyperemia, posterior commissural hypertrophy, and granulation. 13, 14 Studies of culture methods might have underestimated the prevalence of H pylori in the oral cavity, but polymerase chain reaction (PCR) may be a promising tool for detecting H pylori because of its high sensitivity and specificity. 8, 12 In this study, we aimed to determine if there was any association among the presence of H pylori, LPR, and laryngeal lesions. All patients were asked about the presence of the classic symptoms of gastroesophageal reflux disease and LPR. A reflux symptom index (RSI) was established for all patients on the basis of their answers in the RSI questionnaire (figure 1). 15 Then all patients underwent a physical examination, including a second endoscopic assessment of the larynx in which the physician determined their reflux finding score (RFS) (figure 2). 16 Patients with an RSI of 14 or more and/or an RFS of 8 or more were considered to have LPR as defined in the recent literature. 14 After these procedures, samples were collected during direct laryngoscopy under general anesthesia for a definitive diagnosis, and they were used for pathologic and microbiologic research.
Patients and methods
DNA extraction from samples was performed with a commercial spin-column DNA extraction kit (QIAamp DNA Mini Kit; Qiagen; Valencia, Calif.) protocol according to the manufacturer's instructions except that the initial lysis step was extended to an overnight incubation at 56°C. For real-time PCR detection of H pylori in tissues, a commercial assay that targets a 156-bp portion on the ureC gene of the H pylori genome (Fluorion Helicobacter pylori DNA Detection Kit H. pylori-QLS 1.0; Iontek Biotechnology; Istanbul) was used in accordance with the manufacturer's recommendations in a thermal cycler (iCycler IQ Thermal Cycler; Bio-Rad Laboratories; Hercules, Calif.). Previously identified H pylori strains processed as described above were used as a positive control in the PCR assays.
We used the Statistical Package for the Social Sciences software (v. 13.0; SPSS; Chicago) for statistical analysis. We used descriptive statistical methods for analyzing study data. Also, we analyzed the presence of H pylori, LPR, and other variables by using the chi-square and Fischer exact tests. Results were evaluated with a confidence interval of 95%, and a p value of less than 0.05 was considered statistically significant.
The study protocol was approved by the local ethics committee, and informed consent was obtained from all patients. 
Results
H pylori was present in 24 patients (55.8%) and absent in 19 (44.2%) (table 1), indicating that there was no statistically significant association between the presence or absence of H pylori and the presence of laryngeal lesions. LPR was present in 30 patients (69.8%) and absent in 13 (30.2%) (table 1). This high rate of LPR positivity in patients with laryngeal lesions was statistically significant (p = 0.01). Also, the ratio of LPR positivity and negativity happened to be identical to the ratio of smoking positivity and negativity, but these ratios represented different patients.
H pylori was present in 18 of the 30 LPR-positive patients (60.0%) and in 6 of the 13 LPR-negative patients (46.2%) (table 1). There was no statistically significant difference between the proportion of LPR-positive and -negative patients according to H pylori status.
Pathologic examination of the laryngeal tissue samples identified benign entities such as nodules, papillomas, hemangiomas, myofibroblastic tumors, polyps, and chronic inflammation, as well as several malignant/premalignant lesions such as dysplasias and squamous cell carcinomas. A total of 22 patients (51.2%) had a benign lesion and 21 patients (48.8%) had a malignant/premalignant lesion. LPR was present in 14 of the patients with a benign lesion (63.6%) and in 16 of the patients with a malignant-premalignant lesion (76.2%) (table 2). There was a statistically significant relationship between LPR positivity and the presence of a malignant/premalignant lesion (p = 0.03). Conversely, there was no association between the presence of H pylori and either benign or malignant/premalignant lesions (table 2) .
Discussion
The role of LPR in the development of several otolaryngologic disorders is controversial. The estimated prevalence of LPR-related disorders in otolaryngology practice ranges from 4 to 10%. 17 The reported prevalence of LPR in patients with voice and laryngeal disorders ranges as high as 50 to 78%. 18 H pylori is one of the most common infections in the world, affecting more than 50% of the global population. 19 Its prevalence is 30 to 40% in developed countries and 80 to 90% in underdeveloped countries. 20 H pylori is accepted as an agent responsible for gastritis, and it is suspected in many systemic infections. The primary reservoir of H pylori is believed to be stomach; other reservoirs include atheroma plaques of the coronary arteries, dental plaque, tonsil and adenoid tissue, and squamous cell carcinoma of the larynx. 9, [21] [22] [23] LPR has been of special interest in the study of otolaryngologic diseases in recent years, and some reflux-related extraesophageal symptoms have been recognized recently. A variety of atypical extraesophageal manifestations-including dysphagia, globus pharyngeus, hoarseness, odynophagia, sore throat, postnasal drip, cough, throat clearing, laryngospasm, and voice fatigue-were defined. It is also well recognized that many patients with these symptoms lack the classic symptoms of gastroesophageal reflux disease, such as heartburn and regurgitation. 12, 24, 25 Belafsky et al used symptoms and findings of reflux for determining the presence of LPR and advocated that clinicians must realize that the diagnosis of LPR is based on a combination of both symptoms and diagnostic test results. 14 The relationship between H pylori and LPR is still unclear. Some authors have supported the idea that H pylori infection might be protective in LPR, and some have opposed it. 5, 26 In our study, we found that there was no significant relationship between H pylori and LPR.
Different methods can be used to detect H pylori infection. Invasive techniques include culture, biopsy, the CLO (Campylobacter-like organisms) test, and PCR. Noninvasive techniques include serology and the C-urea breath test. Culture is technically difficult and is reported to be the least sensitive method for the detection of H pylori. The advantage of PCR is that it has an excellent sensitivity and specificity, but it has two drawbacks: the risk of false-positive results and the need for special equipment and interpretation. 27 For detecting H pylori, real-time PCR is more sensitive than standard PCR, and it is a specific test used for the detection of active H pylori infection. We used real-time PCR in our study. In 43 specimens, we found that the prevalence of H pylori positivity in patients with laryngeal lesions was not statistically significant. Subgroup analysis showed no association between benign (51.2%) and malignant/ premalignant (48.8%) lesions related to H pylori.
The prevalence of LPR in the patients with laryngeal lesions was 69.8%, and this finding is statistically significant. LPR was present in 63.6% of patients with benign lesions and in 76.2% of those with malignant or premalignant lesions. As some authors 18 have reported a relationship between LPR and laryngeal carcinoma, we found a correlation between LPR and malignant/ premalignant lesions in our study. As a result, LPR was associated with a higher risk of laryngeal pathologies, and it is more prominent for malignant-premalignant lesions. 
